このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

KYORIN Pharmaceutical マネジメント

マネジメント基準チェック /14

KYORIN Pharmaceutical'sの CEO はYutaka Ogiharaで、 Jun2019年に任命され、の在任期間は 5.08年です。は、会社の株式の13.63%を直接所有しており、その価値は¥ 13.33B 。経営陣と取締役会の平均在任期間はそれぞれ0.5年と5.6年です。

主要情報

Yutaka Ogihara

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	5.1yrs
CEOの所有権	13.6%
経営陣の平均在職期間	less than a year
取締役会の平均在任期間	5.6yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Yutaka Ogihara (57 yo)

5.1yrs

在職期間

Mr. Yutaka Ogihara has been Executive Director at KYORIN Pharmaceutical Co., Ltd. since June 2019. He has been Representative Director, President and Chief Executive Officer of KYORIN Holdings, Inc. since...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Yutaka Ogihara	President	5.1yrs	データなし	13.63% ¥ 13.3b
Yasuji Kurose	CFO, CStO	no data	データなし	データなし
Kiyoo Uehara	Corporate Officer	less than a year	データなし	データなし
Michiro Onota	Executive Director & CMO	no data	データなし	0.022% ¥ 21.5m
Takaaki Kaji	Executive Officer	no data	データなし	データなし
Noriaki Tamura	Executive Officer	no data	データなし	データなし
Junichi Ishiyama	Executive Officer	no data	データなし	データなし
Kimiya Masada	Corporate Officer & Director of Product Strategy	less than a year	データなし	データなし
Hiroshi Hashizume	Executive Officer	no data	データなし	データなし
Makoto Yanai	Executive Officer & Deputy GM of Business Development Division	no data	データなし	データなし
Katsuhiro Hamada	Executive Officer & GM of Reliability Assurance Headquarters	no data	データなし	データなし

0.5yrs

平均在職期間

経験豊富な経営陣: 4569の経営陣は経験豊富とはみなされません ( 0.4年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Yutaka Ogihara	President	13.1yrs	データなし	13.63% ¥ 13.3b
Yasuji Kurose	CFO, CStO	less than a year	データなし	データなし
Michiro Onota	Executive Director & CMO	7.1yrs	データなし	0.022% ¥ 21.5m
Hiroshi Hashizume	Executive Officer	no data	データなし	データなし
Tomiharu Matsumoto	Chairman of Corporate Auditors	6.1yrs	データなし	0.035% ¥ 34.4m
Kenji Akutsu	Senior Corporate Auditor	2.1yrs	データなし	0.022% ¥ 21.3m
Takao Yamaguchi	Outside Member of Audit & Supervisory Board	no data	データなし	0.0038% ¥ 3.7m
Noriyuki Shikanai	Independent Outside Director	11.1yrs	データなし	0.0077% ¥ 7.5m
Ken Shigematsu	Independent Outside Director	7.1yrs	データなし	0.0073% ¥ 7.1m
Hiromi Watanabe	Independent Outside Director	5.1yrs	データなし	0.0031% ¥ 3.0m
Yukio Ikemura	Outside Audit & Supervisory Board Member	2.1yrs	データなし	0.00035% ¥ 340.6k
Kensuke Morita	Outside Audit & Supervisory Board Member	2.1yrs	データなし	0.00035% ¥ 340.6k

5.6yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: 4569の取締役会は経験豊富であると考えられます ( 6.5年の平均在任期間)。

KYORIN Pharmaceutical マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

KYORIN Pharmaceutical Co., Ltd., Annual General Meeting, Jun 21, 2024

KYORIN Pharmaceutical Co., Ltd., Annual General Meeting, Jun 23, 2023

Less than half of directors are independent

KYORIN Holdings, Inc., Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

KYORIN Pharmaceutical Co., Ltd. to Report Q1, 2025 Results on Jul 31, 2024

Consensus EPS estimates fall by 14%, revenue upgraded

Price target decreased by 13% to JP¥1,300

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

KYORIN Pharmaceutical Co., Ltd., Annual General Meeting, Jun 21, 2024

KYORIN Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on May 10, 2024

KYORIN Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on May 10, 2024

Upcoming dividend of JP¥32.00 per share

Now 20% overvalued

Third quarter 2024 earnings released: EPS: JP¥37.55 (vs JP¥54.71 in 3Q 2023)

New minor risk - Profit margin trend

Second quarter 2024 earnings released: EPS: JP¥18.85 (vs JP¥1.03 in 2Q 2023)

Upcoming dividend of JP¥20.00 per share at 2.9% yield

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: JP¥11.80 (vs JP¥20.65 in 1Q 2023)

KYORIN Pharmaceutical Co., Ltd. to Report Q2, 2024 Results on Nov 08, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

KYORIN Pharmaceutical Co., Ltd., Annual General Meeting, Jun 23, 2023

Upcoming dividend of JP¥32.00 per share at 3.1% yield

Third quarter 2023 earnings released: EPS: JP¥54.71 (vs JP¥41.22 in 3Q 2022)

Second quarter 2023 earnings released: EPS: JP¥1.03 (vs JP¥10.17 in 2Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥1.03 (vs JP¥10.17 in 2Q 2022)

Upcoming dividend of JP¥20.00 per share

First quarter 2023 earnings released: EPS: JP¥20.65 (vs JP¥8.06 loss in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

KYORIN Holdings, Inc., Annual General Meeting, Jun 24, 2022

KYORIN Holdings, Inc. to Report Q2, 2023 Results on Nov 09, 2022

Consensus EPS estimates increase by 47%

Less than half of directors are independent

Upcoming dividend of JP¥32.00 per share

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

KYORIN Holdings, Inc. to Report Fiscal Year 2022 Results on May 11, 2022

Second quarter 2022 earnings released: EPS JP¥10.17 (vs JP¥8.88 in 2Q 2021)

Upcoming dividend of JP¥20.00 per share

Consensus EPS estimates fall to JP¥52.53

Price target decreased to JP¥1,700

Full year 2021 earnings released: EPS JP¥107 (vs JP¥107 in FY 2020)

Full year 2021 earnings released: EPS JP¥107 (vs JP¥107 in FY 2020)

Upcoming dividend of JP¥45.00 per share

New 90-day high: JP¥2,019

Third quarter 2021 earnings released: EPS JP¥41.64 (vs JP¥61.80 in 3Q 2020)

KYORIN Holdings, Inc. to Report Fiscal Year 2020 Results on May 12, 2021

New 90-day high: JP¥2,008

Price target raised to JP¥2,100

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14